|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities | ||||
| Net income (loss) including noncontrolling interests | ||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||||
| Equity method and other investments loss (income) | ||||
| Loss on sale of equity method investments | ||||
| Depreciation and amortization | ||||
| Share-based compensation | ||||
| Fair value adjustment to warrant liability | ||||
| Issuance of ordinary shares related to commitment shares | ||||
| Impairment loss on investments in loans and securities/loss on loans held-for-investment | ||||
| Asset-Backed Securities | ||||
| Other loans and receivables | ||||
| Total impairment loss on investments in loans and securities/loss on loans held-for-investment | ||||
| Gain on sale of investments in loans and securities | ||||
| Other than temporary impairment of investments in loans and securities | ||||
| (Gains) and losses on investments in loans and securities | ||||
| Write-off of capitalized software and other assets | ||||
| Amortization of deferred costs | ||||
| Losses (gains) from extinguishment of debt | ||||
| Losses (gains) on foreign exchange | ||||
| Other non-cash items | ||||
| Change in operating assets and liabilities: | ||||
| Fees and other receivables | ||||
| Deferred tax assets, net | ||||
| Fees receivables | ||||
| Accrued interest on investments | ||||
| Right-of-use assets | ||||
| Other assets | ||||
| Accounts payable | ||||
| Accrued expenses and other liabilities | ||||
| Operating lease liability | ||||
| Income tax receivable / payable | ||||
| Income taxes | ||||
| Net cash provided by (used in) operating activities | ||||
| Cash flows from investing activities | ||||
| Investments in loans and securities | ||||
| Short-term deposits | ||||
| Proceeds from the maturity and prepayment of investments in loans and securities | ||||
| Proceeds from the sales of investments in loans and securities | ||||
| Proceeds from equity method and other investments | ||||
| Cash and restricted cash acquired from Darwin Homes, Inc. | ||||
| Purchases of investments in loans and securities | ||||
| Purchases of property, equipment and software | ||||
| Purchases of intangible assets | ||||
| Purchases of equity method and other investments | ||||
| Purchases of other assets | ||||
| Acquisition of Theorem Technology, Inc., net of cash acquired | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities | ||||
| Proceeds from sale of ordinary shares, net of issuance costs | ||||
| Proceeds from sale of ordinary shares in connection with the Business Combination and PIPE Investment, net of issuance costs | ||||
| Proceeds from long-term debt | ||||
| Proceeds from exchangeable notes | ||||
| Proceeds from issuance of redeemable convertible preferred shares, net | ||||
| Proceeds from issuance of ordinary share warrants, net | ||||
| Proceeds from secured borrowing | ||||
| Proceeds received from noncontrolling interests | ||||
| Proceeds from revolving credit facility | ||||
| Proceeds from exercise of stock options, warrants and contributions to ESPP | ||||
| Proceeds from exercise of redeemable convertible preferred shares warrants | ||||
| Distributions made to noncontrolling interests | ||||
| Payments made to revolving credit facility | ||||
| Payments made to secured borrowing | ||||
| Payments made to long-term debt | ||||
| Debt issuance costs | ||||
| Settlement of share-based compensation in satisfaction of tax withholding requirements | ||||
| Payments for deferred offering costs | ||||
| Net cash provided by financing activities | ||||
| Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents | ||||
| Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents | ||||
| Cash and cash equivalents, and restricted cash and cash equivalents, beginning of period | ||||
| Cash and cash equivalents, and restricted cash and cash equivalents, end of period | ||||
| Supplemental disclosures of cash flow information | ||||
| Cash paid for income taxes | ||||
| Cash paid for interest expense | ||||
| Cash paid for operating leases | ||||
| Supplemental disclosure of non-cash activities | ||||
| Initial recognition (derecognition) of right-of-use assets and operating lease liability | ||||
| In-kind distributions | ||||
| Issuance of ordinary shares in connection with acquisitions | ||||
| Deemed dividend from secondary transactions | ||||
| Issuance of redeemable convertible preferred shares upon exercise of warrants | ||||
| Stock-based compensation included in capitalized internal-use software | ||||
| Contingent consideration liability in connection with the acquisition of Theorem | ||||
| Reconciliation of cash and cash equivalents, and restricted cash and cash equivalents within the consolidated balance sheet to the amounts shown in the statements of cash flow above: | ||||
| Cash and cash equivalents | ||||
| Restricted cash - current | ||||
| Restricted cash - non-current | ||||
| Restricted cash and cash equivalents | ||||
Loading...
